Your Nexa provider titrates your dose based on response, tolerance, and goals with unlimited follow-ups included to adjust your plan as you progress
Mazdutides development represents a significant advancement in peptide engineering as a new molecular entity designed to address multifactorial metabolic diseases including type 2 diabetes (T2D), obesity, and related comorbidities
Cerebrovascular disease is also more prevalent in individuals with diabetes, increasing the risk of transient ischemic attacks and strokes
BPC-157 demonstrates a favorable safety profile in research studies, with minimal adverse effects reported across hundreds of animal studies
however, it should be noted that this was not a large increase, as it was only an increase of 0.2 percentage points between 2020 to 2024 (1.3% to 1.5%)
The relevance to humans is not established, but if you notice a neck lump, difficulty swallowing, persistent hoarseness, or unexplained neck pain, inform your clinician promptly